Price loading...

The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies in Japan

Price data last checked 102 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
28 November 2022
Listed Since
07 December 2022

Similar Products You Might Like

The 2023-2028 Outlook for Bone Marrow Transplants in Japan
98% match

The 2023-2028 Outlook for Bone Marrow Transplants in Japan

£495.00 08 Jan 2026
The 2023-2028 Outlook for Multiple Myeloma Therapeutics in Japan
97% match

The 2023-2028 Outlook for Multiple Myeloma Therapeutics in Japan

£495.00 10 Jan 2026
The 2023-2028 Outlook for Multiple Myeloma Treatments in Japan
97% match

The 2023-2028 Outlook for Multiple Myeloma Treatments in Japan

£495.00 13 Jan 2026
The 2023-2028 Outlook for Monoclonal Antibodies Protein Therapeutics in Japan
96% match

The 2023-2028 Outlook for Monoclonal Antibodies Protein Therapeutics in Japan

£495.00 09 Jan 2026
The 2023-2028 Outlook for Natural Killer Cell Therapeutics in Japan
96% match

The 2023-2028 Outlook for Natural Killer Cell Therapeutics in Japan

£495.00 25 Jan 2026
The 2023-2028 Outlook for Cell Culture in Healthcare in Japan
96% match

The 2023-2028 Outlook for Cell Culture in Healthcare in Japan

£495.00 16 Dec 2025
The 2023-2028 Outlook for Bone Growth Stimulators in Japan
96% match

The 2023-2028 Outlook for Bone Growth Stimulators in Japan

£495.00 23 Jan 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in Japan
96% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in Japan

£495.00 09 Jan 2026
The 2023-2028 Outlook for Erythropoietin Drugs in Japan
96% match

The 2023-2028 Outlook for Erythropoietin Drugs in Japan

£495.00 12 Jan 2026
The 2023-2028 Outlook for Internal Beam Radiotherapy in Japan
96% match

The 2023-2028 Outlook for Internal Beam Radiotherapy in Japan

£495.00 11 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan

£495.00 24 Jan 2026
The 2023-2028 Outlook for Proton Therapies in Japan - Book
96% match

The 2023-2028 Outlook for Proton Therapies in Japan - Book

£495.00 07 Mar 2026
The 2023-2028 Outlook for Sarcopenia Treatments in Japan
96% match

The 2023-2028 Outlook for Sarcopenia Treatments in Japan

£495.00 08 Jan 2026
The 2023-2028 Outlook for External Beam Radiation Oncology Therapies in Japan
96% match

The 2023-2028 Outlook for External Beam Radiation Oncology Therapies in Japan

£495.00 24 Jan 2026
The 2023-2028 Outlook for Recombinant Plasma Protein Therapeutics in Japan
96% match

The 2023-2028 Outlook for Recombinant Plasma Protein Therapeutics in Japan

£495.00 07 Jan 2026
The 2023-2028 Outlook for Protein Therapeutics in Japan
96% match

The 2023-2028 Outlook for Protein Therapeutics in Japan

£495.00 12 Jan 2026
The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in Japan
96% match

The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in Japan

£495.00 12 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in Japan
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in Japan

£495.00 13 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in Japan
96% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in Japan

£495.00 22 Jan 2026
The 2023-2028 Outlook for External Beam Radiotherapy in Japan
96% match

The 2023-2028 Outlook for External Beam Radiotherapy in Japan

£495.00 12 Jan 2026
The 2023-2028 Outlook for Osteoporosis Treatments in Japan
96% match

The 2023-2028 Outlook for Osteoporosis Treatments in Japan

£495.00 13 Jan 2026
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in Japan
96% match

The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in Japan

£495.00 08 Feb 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in Japan
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in Japan

£495.00 27 Jan 2026
The 2023-2028 Outlook for Therapeutic-Protein Biological Drugs in Japan
96% match

The 2023-2028 Outlook for Therapeutic-Protein Biological Drugs in Japan

£495.00 12 Jan 2026